journal article·2012-08

Synthesis and characterization of Mg‐Ca‐Sr alloys for biodegradable orthopedic implant applications

Ida S. Berglund, Harpreet S. Brar, Natalia Dolgova, Abhinav P. Acharya, Benjamin G. Keselowsky, Malisa Sarntinoranont, Michele V. Manuel

Publisher page

Abstract

Abstract Magnesium has recently received an increased amount of interest due to its potential use in biodegradable implant applications. The rapid degradation of conventional Mg is, however, a major limitation that needs to be addressed in the design of these materials, along with consideration of toxicity in selection of alloying elements. In this study, five alloys in the Mg‐xCa‐ySr system (x= 0.5–7.0 wt %;y= 0.5–3.5 wt %) were prepared and characterized for their suitability as degradable orthopedic implant materials. The alloys were characterized using optical microscopy, scanning electron microscopy, energy‐dispersive X‐ray spectroscopy, X‐ray diffraction, degradation measurements in Hanks' solution at 37°C, compression testing, andin vitrocytotoxicity testing with a mouse osteoblastic cell line. The results indicate that the Mg‐1.0Ca‐0.5Sr alloy is the most promising alloy for orthopedic implant applications since it showed the lowest degradation rate in Hanks' solution (0.01 mL cm−2h−1) along with no significant toxicity to MC3T3‐E1 osteoblasts and a compressive strength of 274 ± 4 MPa. © 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 100B: 1524–1534, 2012.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Magnesium Alloys: Properties and Applications · Aluminum Alloys Composites Properties · Metal and Thin Film Mechanics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (56)

Show source-provided references
1. 10.1007/s11837-011-0048-810.1007/s11837-011-0048-8 ↗
2. 10.1007/s11837-009-0129-010.1007/s11837-009-0129-0 ↗
3. 10.1136/heart.89.6.65110.1136/heart.89.6.651 ↗
4. 10.1016/j.biomaterials.2007.12.02110.1016/j.biomaterials.2007.12.021 ↗
5. 10.1111/j.1540-8183.2004.04081.x10.1111/j.1540-8183.2004.04081.x ↗
6. 10.1002/adem.20060025210.1002/adem.200600252 ↗
7. 10.1016/j.biomaterials.2006.12.02710.1016/j.biomaterials.2006.12.027 ↗
8. 10.1016/j.biomaterials.2004.09.04910.1016/j.biomaterials.2004.09.049 ↗
9. 10.1002/jbm.b.3168710.1002/jbm.b.31687 ↗
10. 10.1007/s11837-011-0066-610.1007/s11837-011-0066-6 ↗
11. 10.1016/S0010-938X(97)00090-510.1016/S0010-938X(97)00090-5 ↗
12. 10.1002/978047053177810.1002/9780470531778 ↗
13. 10.1016/S0022-0728(74)80298-610.1016/S0022-0728(74)80298-6 ↗
14. 10.1533/978085709141310.1533/9780857091413 ↗
15. New interests in magnesium
16. Avedesian MM · 1999
17. 10.1016/j.biomaterials.2005.10.00310.1016/j.biomaterials.2005.10.003 ↗
18. Venugopal B · 1978
19. 10.1149/1.204998110.1149/1.2049981 ↗
20. 10.1080/10667857.2001.1175292010.1080/10667857.2001.11752920 ↗
21. 10.1016/j.cossms.2009.04.00110.1016/j.cossms.2009.04.001 ↗
22. 10.1016/j.corsci.2007.01.00110.1016/j.corsci.2007.01.001 ↗
23. 10.1149/1.284443310.1149/1.2844433 ↗
24. 10.1007/s10856-010-4111-810.1007/s10856-010-4111-8 ↗
25. 10.1016/j.actbio.2008.07.03410.1016/j.actbio.2008.07.034 ↗
26. 10.1080/1748296080193401510.1080/17482960801934015 ↗
27. 10.1006/faat.1997.232210.1006/faat.1997.2322 ↗
28. 10.1016/S1043-6618(02)00336-510.1016/S1043-6618(02)00336-5 ↗
29. 10.1590/S0104-1169200800010002310.1590/S0104-11692008000100023 ↗
30. 10.1016/S0142-9612(01)00266-610.1016/S0142-9612(01)00266-6 ↗
31. Effect of low‐doses of strontium on bone metabolism in rats
32. 10.1016/8756-3282(96)00080-410.1016/8756-3282(96)00080-4 ↗
33. 10.1016/S8756-3282(01)00419-710.1016/S8756-3282(01)00419-7 ↗
34. 10.1007/s00198-004-1753-810.1007/s00198-004-1753-8 ↗
35. 10.1007/978-1-4899-0167-510.1007/978-1-4899-0167-5 ↗
36. Improvement in bone strength parameters. The role of strontium ranelate
37. 10.1007/BF0283034910.1007/BF02830349 ↗
38. 10.1016/j.jmbbm.2011.07.01810.1016/j.jmbbm.2011.07.018 ↗
39. 10.1016/j.matdes.2008.04.01710.1016/j.matdes.2008.04.017 ↗
40. Ashby MF · 2011 · xv
41. 10.1016/j.actamat.2009.04.03810.1016/j.actamat.2009.04.038 ↗
42. 10.4028/www.scientific.net/AMR.32.20710.4028/www.scientific.net/AMR.32.207 ↗
43. 10.1088/1748-6041/5/4/04500510.1088/1748-6041/5/4/045005 ↗
44. 10.1016/j.actbio.2009.10.00810.1016/j.actbio.2009.10.008 ↗
45. 10.1016/j.biomaterials.2008.10.02110.1016/j.biomaterials.2008.10.021 ↗
46. Development and biocompatibility of a novel corrodible fluoride‐coated magnesium‐calcium alloy with improved degradation kinetics and adequate mechanical properties for cardiovascular applications10.1002/jbm.a.32582 ↗
47. 10.1016/j.matlet.2008.06.02810.1016/j.matlet.2008.06.028 ↗
48. 10.1016/S0364-5916(02)00034-210.1016/S0364-5916(02)00034-2 ↗
49. 2007
50. 10.1016/j.jallcom.2008.01.08410.1016/j.jallcom.2008.01.084 ↗
51. 10.1002/adem.20080004610.1002/adem.200800046 ↗
52. 10.5006/1.346291210.5006/1.3462912 ↗
53. 10.1557/jmr.2007.023310.1557/jmr.2007.0233 ↗
54. Cowin SC · 1989
55. 10.1016/j.actbio.2009.09.02410.1016/j.actbio.2009.09.024 ↗
56. 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E ↗